Genetic Testing Market, By Type (Carrier Testing, Diagnostic Testing, Newborn Screening, Predictive and Presymptomatic Testing, Prenatal Testing, and Other Types), By Disease (Alzheimer’s Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s Disease, Rare Diseases, and Other Diseases), By Technology (Cytogenetic Testing, Biochemical Testing, and Molecular Testing), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI388820 | Publish Date: May 2024 | No. of Pages: 180

Global Genetic Testing Market By Overview

Genetic Testing Market accounted for US$ 11.0 Billion in 2024 and is estimated to be US$ 24.2 Billion by 2034 and is anticipated to register a CAGR of 9.0%.

Genetic testing is the study of the gene present in cells and tissues. This study is further applied in the field of medicine and biology to better understand genetic disorders such as cancer, cystic fibrosis, sickle cell anaemia, Down syndrome, and others. Genetic testing technology (laboratory developed test (LDT) and direct-to-customer) has undergone significant improvements after the technology came into existence. With scientific advancements in genomics, genetic testing has become a common procedure in clinics. In addition, the adoption rate for direct-to consumer is high and is expected to increase over the forecast period. Regulatory authorities (such as Food and Drug Administration (FDA) and European Medicines Agency (EMA)) and insurance providers (such as Centers for Medicare and Medicaid Services (CMS), and others) have not been able to improve their guidelines, with changing technology and environment. The current legislation has given enforcement agencies the discretionary power for premarket review and quality system requirements, for both traditional and rare disease LDTs. Although this discretionary power can be helpful in increasing the efficiency and efficacy, it delays the overall process, which is not good for such a rapidly evolving, technology-oriented market. As a result, there has been a struggle between the market players and regulatory authorities. For instance, the 23andme Company markets personal genetic tests directly to customers and has been operating in a similar way, since 2006. In 2013, owing to the company’s failure to provide information to back its marketing claims, the FDA banned its personal genetic test kits. The continuous tussle between market players and regulatory authorities, with respect to evolving technology, presents a challenging environment for the new and established players in the market.

Global Genetic Testing Market By Dynamics

Rise in incidence of genetic disorders

The rise in the incidence of genetic disorders & cancer and growth in awareness & acceptance of personalized medicines is the major factor driving the growth of the genetic testing market. Also, increasing the application of genetic testing and advancements in genetic testing techniques in oncology are projected to boost the target market growth over the forecast period. According to the data published by NCBI, in August 2017, there were about 75,000 genetic tests available in the market, these include an approximate of 10,000 unique tests. Also, there has been an addition of more than 14,000 tests in the market since March 2014.

However, stringent regulatory requirements for product approvals and standardization concerns regarding genetic testing-based diagnostics are expected to hamper the genetic testing market growth over the forecast period. Nevertheless, untapped emerging markets in developing countries are estimated to provide lucrative growth opportunities for global market players. Therefore, these factors are anticipated to propel the genetic testing market share.

Global Genetic Testing Market By Segmentation

The genetic testing market is segmented based on type, disease, technology, and region.

Based on type, the genetic testing market is segmented into carrier testing, diagnostic testing, newborn screening, predictive and presymptomatic testing, prenatal testing, and other types. Based on disease, the target market is classified into Alzheimer’s disease, cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s disease, Rare Diseases, and Other Diseases. Based on technology, the target market is classified into cytogenetic testing, biochemical testing, and molecular testing.

Region:

On the region, the genetic testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2017, North America was the leading revenue contributor to the genetic testing market and is projected to dominate the market over the forecast period. This is mainly credited due to the occurrence of the majority of key players in this region. Moreover, Asia-Pacific is anticipated to grow at the highest CAGR over the forecast period, owing to a surge in healthcare expenditure, increase in affordability, and growth in awareness toward early screening of genetic disorders.

Genetic Testing Market Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Type - Carrier Testing, Diagnostic Testing, Newborn Screening, Predictive And Presymptomatic Testing, Prenatal Testing, And Other Types

By Disease– Alzheimer’s disease, cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s disease, Rare Diseases, and Other Diseases

By Technology- Cytogenetic Testing, Biochemical Testing, And Molecular Testing

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Genetic Testing Market, By Type:

  • Carrier Testing
  • Diagnostic Testing
  • Newborn Screening
  • Predictive and Presymptomatic Testing
  • Prenatal Testing
  • Other Types

Genetic Testing Market, By Disease:

  • Alzheimer’s disease
  • Cancer
  • Cystic Fibrosis
  • Sickle Cell Anemia
  • Duchenne Muscular Dystrophy
  • Thalassemia
  • Huntington ’s disease
  • Rare Diseases
  • Other Diseases

Genetic Testing Market, By Technology:

  • Cytogenetic Testing
  • Biochemical Testing
  • Molecular Testing

Genetic Testing Market, By Region:

  • North America
    • Middle East & Africa
      • Middle East & Africa Genetic Testing Market, By Type
      • Middle East & Africa Genetic Testing Market, By Disease
      • Middle East & Africa Genetic Testing Market, By Technology
      • Middle East & Africa Genetic Testing Market, By Country
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
      • Latin America Genetic Testing Market, By Type
      • Latin America Genetic Testing Market, By Disease
      • Latin America Genetic Testing Market, By Technology
      • Latin America Genetic Testing Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
      • Asia Pacific Genetic Testing Market, By Type
      • Asia Pacific Genetic Testing Market, By Disease
      • Asia Pacific Genetic Testing Market, By Technology
      • Asia Pacific Genetic Testing Market, By Country
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
      • Europe Genetic Testing Market, By Type
      • Europe Genetic Testing Market, By Disease
      • Europe Genetic Testing Market, By Technology
      • Europe Genetic Testing Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • North America Genetic Testing Market, By Type
    • North America Genetic Testing Market, By Disease
    • North America Genetic Testing Market, By Technology
    • North America Genetic Testing Market, By Country
      • U.S.
      • Canada

Global Genetic Testing Market By Key Players

The key players operating the genetic testing market 23andMe, Abbott Laboratories Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation (Cepheid), Genesis Healthcare, Illumina Inc., Luminex Corporation, Eurofins Scientific SE (Eurofins), and Myriad Genetics Inc. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the types to gain a competitive edge in the target market. For instance, in March 2018, Thermo Fisher Scientific acquired IntegenX, a provider of leading rapid DNA technology for human identification.

Global Genetic Testing Market By Company Profile

  • 23andMe
  • Abbott Laboratories Inc.
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation (Cepheid)
  • Genesis Healthcare
  • Illumina Inc.
  • Luminex Corporation
  • Eurofins Scientific SE (Eurofins)
  • Myriad Genetics Inc.

Global Genetic Testing Market By Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Industry Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for Genetic Testing Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Type
      • Market Snippet, By Disease
      • Market Snippet, By Technology
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Carrier Testing
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Diagnostic Testing
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Newborn Screening
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Predictive and Presymptomatic Testing
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Prenatal Testing
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Types
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Market Segmentation, By Disease, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Alzheimer’s Disease
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cancer
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cystic Fibrosis
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Sickle Cell Anemia
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Duchenne Muscular Dystrophy
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Thalassemia
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Huntington’s Disease
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Rare Diseases
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Diseases
      • Overview
      • Market Disease and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Disease and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Disease, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Disease and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Disease, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Disease and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Disease, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Disease and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Disease, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Disease and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Disease, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Disease and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  9. Company Profiles
      • 23andMe
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • Abbott Laboratories Inc.
      • Bio-Rad Laboratories
      • F. Hoffmann-La Roche Ltd.
      • Danaher Corporation (Cepheid)
      • Genesis Healthcare
      • Illumina, Inc.
      • Luminex Corporation
      • Eurofins Scientific SE (Eurofins)
      • Myriad Genetics Inc.
  10. The Last Word
    • Future Impact
    • About Us
    • Contact 

FAQs

Genetic Testing Market accounted for US$ 11.0 Billion in 2024 and is estimated to be US$ 24.2 Billion by 2034 and is anticipated to register a CAGR of 9.0%.

Genetic Testing Market is projected to increase at a CAGR of 9.0% during the forecast period.

Genetic testing market is segmented based on type, disease, technology, and region.

The rise in the incidence of genetic disorders & cancer and growth in awareness & acceptance of personalized medicines is the major factor driving the growth of the global genetic testing market.